Stay updated with breaking news from Tprds. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pardes Biosciences (NASDAQ:PRDS – Get Rating) was downgraded by stock analysts at Jefferies Financial Group from a “buy” rating to a “hold” rating in a research note issued on Monday, The Fly reports. Several other equities research analysts have also recently commented on the stock. JMP Securities cut their price target on shares of Pardes […]
TD Asset Management Inc. trimmed its holdings in Pardes Biosciences, Inc. (NASDAQ:PRDS – Get Rating) by 36.3% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 26,500 shares of the company’s stock after selling 15,105 shares during the period. TD Asset Management […]
Equities research analysts predict that Pardes Biosciences, Inc. (NASDAQ:PRDS – Get Rating) will announce earnings of ($0.39) per share for the current fiscal quarter, according to Zacks. Zero analysts have issued estimates for Pardes Biosciences’ earnings, with the lowest EPS estimate coming in at ($0.40) and the highest estimate coming in at ($0.38). The company […]
Wall Street analysts predict that Pardes Biosciences, Inc. (NASDAQ:PRDS – Get Rating) will post earnings per share of ($0.25) for the current quarter, Zacks reports. Zero analysts have made estimates for Pardes Biosciences’ earnings. The highest EPS estimate is ($0.23) and the lowest is ($0.27). The company is expected to issue its next earnings report […]
Pardes Biosciences Inc (NASDAQ:PRDS – Get Rating) – Equities researchers at SVB Leerink lowered their FY2023 EPS estimates for Pardes Biosciences in a report issued on Wednesday, March 30th. SVB Leerink analyst R. Ruiz now anticipates that the company will post earnings per share of $7.00 for the year, down from their prior estimate of […]